{
    "organizations": [],
    "uuid": "9c2bd3ccd79b4878308247b7ac0599c8ec887c1e",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/02/22/the-associated-press-corcept-misses-4q-profit-forecasts.html",
    "ord_in_thread": 0,
    "title": "Corcept misses 4Q profit forecasts",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "MENLO PARK, Calif. (AP) _ Corcept Therapeutics Inc. (CORT) on Thursday reported fourth-quarter net income of $98.3 million.\nOn a per-share basis, the Menlo Park, California-based company said it had net income of 77 cents. Earnings, adjusted for pretax gains, came to 17 cents per share.\nThe results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 19 cents per share.\nThe drug developer posted revenue of $53.3 million in the period.\nFor the year, the company reported profit of $129.1 million, or $1.04 per share. Revenue was reported as $159.2 million.\nCorcept expects full-year revenue in the range of $275 million to $300 million.\nCorcept shares have dropped 11 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $16.09, a climb of 89 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on CORT at https://www.zacks.com/ap/CORT",
    "published": "2018-02-23T01:31:00.000+02:00",
    "crawled": "2018-02-23T03:09:18.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "menlo",
        "park",
        "ap",
        "corcept",
        "therapeutic",
        "cort",
        "thursday",
        "reported",
        "net",
        "income",
        "million",
        "basis",
        "menlo",
        "park",
        "company",
        "said",
        "net",
        "income",
        "cent",
        "earnings",
        "adjusted",
        "pretax",
        "gain",
        "came",
        "cent",
        "per",
        "share",
        "result",
        "fell",
        "short",
        "wall",
        "street",
        "expectation",
        "average",
        "estimate",
        "three",
        "analyst",
        "surveyed",
        "zacks",
        "investment",
        "research",
        "earnings",
        "cent",
        "per",
        "share",
        "drug",
        "developer",
        "posted",
        "revenue",
        "million",
        "period",
        "year",
        "company",
        "reported",
        "profit",
        "million",
        "per",
        "share",
        "revenue",
        "reported",
        "million",
        "corcept",
        "expects",
        "revenue",
        "range",
        "million",
        "million",
        "corcept",
        "share",
        "dropped",
        "percent",
        "since",
        "beginning",
        "year",
        "final",
        "minute",
        "trading",
        "thursday",
        "share",
        "hit",
        "climb",
        "percent",
        "last",
        "month",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "cort",
        "http"
    ]
}